Wide resection for giant-cell tumor of the distal radius: which reconstruction? A systematic review of the literature and pooled analysis of 176 cases.

Giant-cell tumor (GCT) is often more aggressive when located in the distal radius, and wide resection is then the gold-standard. No single reconstruction protocol is recommended, and the technique depends upon the surgeon's preferences. The aim of the present review was to determine the recurrence rate of GTC of the distal radius after intralesional treatment, to assess the results, advantages and complications of the various surgical techniques, and to draw up a decision-tree for surgical indications. The review of literature was performed in the main healthcare databases, searching for studies that reported results of wide resection and reconstruction of distal radius GCT. Local recurrence rates, metastasis rates, reconstruction techniques and respective results and complications were evaluated and analyzed. Sixteen studies were selected, for a total population of 226 patients; 6.0% and 0.9% experienced local recurrence and lung metastasis, respectively. Arthroplasty with non-vascularized or vascularized ipsilateral fibula were the most common techniques and were associated with the highest satisfaction rates: 86.4% and 88.0%, respectively. Arthroplasty with allograft presented a MusculoSkeletal Tumor Society (MSTS) score of 79.2% and arthroplasty with custom-made prosthesis presented an MSTS score of 81.8%. Arthrodesis was performed in 46 cases, with an MSTS score of 82.7%. Arthroplasty techniques are the most common in literature; they are used in patients who wish to conserve joint motion. Reconstruction with non-vascularized fibula seems to provide the best results, with lower morbidity. Arthrodesis is usually reserved for heavy manual workers or in case of arthroplasty failure.

The relationship of preoperative hematologic parameters to invasion of anatomic structures and recurrence in tenosynovial giant-cell tumor of the digits.

Although the pathogenesis of Teno-Synovial Giant Cell Tumor (TSGCT) is not known, inflammation is thought to play a role in the etiology beside some other factors. Many researchers have found a close relationship between hematological parameters such as Mean Platelet Volume (MPV), Platelet/MPV Ratio (Plt/MPV), Monocyte/Neutrophil Ratio (MNR), Neutrophil/Lymphocyte Ratio (NLR), Platelet/Lymphocyte Ratio (PLR) and certain inflammatory, autoimmune and neoplastic diseases. The aim of the present study was to assess the relationship of hematological parameters (NLR, MNR and Plt/MPV) to tumor recurrence and spread after TSGCT surgery. Data from 102 patients who matched the inclusion criteria comprised preoperative hematological parameters, tumor size, anatomic region, side, presence of bone invasion, proximity to joints or neurovascular structures, and postoperative recurrence and complications. The mean follow-up was 54.2 months (±26.5). Recurrence was observed in 12 (11.8%) of the 102 cases. No significant correlation was found between recurrence and hematologic parameter, age, laterality (right-left) or zone (volar-dorsal). There were no significant differences in NLR, Plt/MPV or MNR between patients with and without bone, capsular, nerve or total involvement. The study thus showed that the various inflammatory parameters (NLR, Plt/MPV and MNR) calculated from blood count were not predictive of tumor invasion into anatomical structures or of digital TSGCT recurrence.

Reconstruction of the distal radius using a double-barrel vascularized fibula flap: A case series.

Treatment of distal radius tumor sometimes requires sacrificing the epiphysis. We propose adding to currently available reconstruction options a technique using a double-barrel vascularized fibula flap fixed distally to the first carpal row, conserving midcarpal mobility. We monitored 4 cases of Campanacci III giant-cell tumor and 2 cases of osteosarcoma. After en-bloc tumor resection, a double-barrel vascularized fibula flap was lodged distally in the scaphoid and lunate and proximally in the radius. Follow-up was clinical and radiological, using DASH, PRWE and MSTS functional scores. At a median 3 years' follow-up, there were no cases of recurrence or non-union. Median ranges of motion were 23° flexion, 28° extension, 90° pronation and 62° supination. Median grip strength proportional to the contralateral side was 67%. Median DASH and PRWE functional scores were respectively 13.7 and 17 points. Median MSTS was 83%. Although this technique is challenging, with difficulties in double-barrel flap placement and in pedicle plication, the double-barrel vascularized fibula flap provided a stable and mobile wrist.

Aberrant sphingomyelin 31P-NMR signatures in giant cell tumour of bone.

An understanding of the biochemistry of the giant cell tumour of bone (GCTB) provides an opportunity for the development of prognostic markers and identification of therapeutic targets. Based on metabolomic analysis, we proposed glycerophospholipid metabolism as the altered pathway in GCTB., The objective of this study was to identify these altered metabolites. Using phosphorus-31 nuclear magnetic resonance spectroscopy (31P-NMR), sphingomyelin was determined to be the most dysregulated phospholipid in tissue samples from six patients with GCTB. Enzymes related to its biosynthesis and hydrolysis were examined using immunodetection techniques. High expression of sphingomyelin synthases 1 and 2, but low expression of neutral sphingomyelinase 2 (nSMase2) was found in GCTB tissues compared to non-neoplastic bone tissues. Sphingomyelin/ceramide biosynthesis is dysregulated in GCTB due to alterations in the expression of SMS1, SMS2, and nSMase2.

Surgical treatment of distal radius giant cell tumors.

We aimed to evaluate the effectiveness of surgical methods commonly used for the clinical treatment of giant cell tumors (GCT) of the distal radius. From 2010 to 2018, 32 patients with GCT of the distal radius who underwent surgical treatment were eligible for the study. Among them, 21 patients with available pathological results, complete imaging data and at least 18 months of follow-up were enrolled in the study. Eleven of the patients underwent en bloc resection and non-vascularized autologous fibula reconstruction (Group A), while 10 patients underwent microwave ablation, lesion curettage, and internal fixation with bone cement (Group B). Imaging was carried out to understand the effect of the surgical treatment and postoperative complications. Variables of interested included operation time and blood loss, preoperative and postoperative wrist joint mobility, and postoperative complications during follow-up. The operation time and intraoperative blood loss in group A were higher than in group B, and the difference between groups was statistically significant. The wrist range of motion before and after surgery was statistically significant both in Group A and Group B (p < 0.05). The scale deviation and MSTS scores of group A were better than group B (p > 0.05), flexion, extension, radial deviation index in group B was better than group A (p < 0.05). By evaluating the postoperative functional outcomes of the operated wrist in the two groups, we found that both surgical methods are reliable for treating GCT of the distal radius, with satisfactory postoperative functional recovery and a low incidence of postoperative recurrence (only 1 of 10 patients in group B). The two surgical methods have their own advantages and disadvantages and provide surgeons with one more choice in the clinical context.

Tumor de células gigantes en cúbito de paciente postrauma / Giant cell tumor in ulna of trauma patient

RESUMEN Introducción: Los tumores de células gigantes pueden originarse en el tejido óseo, sinovial o cualquier otro tejido blando. Se caracterizan por su rápido crecimiento. A pesar de ser comúnmente benignos, si se dejan evolucionar sin tratamiento, hay riesgo de que en su proceso de crecimiento destruyan el tejido adyacente y afecten la funcionalidad, estructura y apariencia de la zona anatómica afectada. Objetivo: Describir el curso clínico y manejo terapéutico de un paciente con tumor de células gigantes en el antebrazo. Caso clínico: Se presenta paciente masculino de 28 años, que se le diagnosticó tumoración ósea en tercio distal del cúbito, y a quien, por su voluntad de no atenderse, no se le realizó el abordaje y manejo quirúrgico. Un año después, regresó al servicio de urgencias. Tenía mayor volumen en las dimensiones tumorales, con cambios a nivel del tercio distal del cúbito, lesiones de patrón lítico, pérdida de la cortical, con reacción perióstica, bordes mal definidos y afectación de tejidos blandos circundantes. Se diagnóstico probable tumor de células gigantes. El manejo quirúrgico permitió la conservación del antebrazo, pero a un año de su intervención quirúrgica, dada la probabilidad de recidiva, su pronóstico permanece incierto. Conclusiones: La velocidad de crecimiento de los tumores de células gigantes amerita decisiones oportunas, dado que el tiempo que transcurre previo al tratamiento puede, como en el presente caso, traducirse en un crecimiento destructivo de los tejidos adyacentes. A más de un año de la cirugía, el pronóstico del paciente es incierto, pues la probabilidad de recidiva permanece latente(AU)

ABSTRACT Introduction: Giant cell tumors can originate in bone, synovial, or any other soft tissue. They are characterized by their rapid growth. Despite being commonly benign, if they are allowed to evolve without treatment, they may destroy adjacent tissue, in its growth process, affecting the functionality, structure and appearance of the affected anatomical area. Objective: To describe the clinical course and therapeutic management of a patient with a giant cell tumor in the forearm. Clinical case: We report the case of a 28-year-old male patient, who was diagnosed with a bone mass in the distal third of the ulna. This patient desired not to undergo surgical management. A year later, he returned to the emergency room. the tumor had greater dimensions, changes at the level of the distal third of ulna, lytic pattern lesions, loss of the cortex, periosteal reaction, poorly defined edges and involvement of surrounding soft tissues. Giant cell tumor was the probable diagnosis. Surgical management allowed the forearm preservation, but one year after surgery, the prognosis remains uncertain, given the probability of recurrence. Conclusions: The growth rate of giant cell tumors merits timely decisions, since the time that elapses prior to treatment can, as in the present case, translate into destructive growth of adjacent tissues. More than a year after surgery, the prognosis is uncertain for this patient, as the probability of recurrence remains latent(AU)

RÉSUMÉ Introduction: Les tumeurs à cellules géantes peuvent être localisées au niveau du tissu osseux, du tissu synovial ou d'un autre tissu mou quelconque. Elles sont caractérisées par une croissance rapide. Malgré leur classique bénignité, si elles évoluent sans traitement, elles risquent de détruire le tissu adjacent et d'altérer la fonction, la structure et l'apparence de la région affectée lors du processus de croissance. Objectif: Décrire l'évolution clinique et la prise en charge thérapeutique d'un patient atteint de tumeur à cellules géantes au niveau de l'avant-bras. Cas clinique: Un patient âgé de 28 ans, diagnostiqué d'une tumeur osseuse au niveau du tiers distal du cubitus, sans abord ni traitement chirurgical dû à son refus de soin, est présenté. Un an après, il est rentré au service d'urgence. La tumeur avait grandi, et présentait des changements au niveau du tiers distal du cubitus, des lésions lytiques, une perte osseuse corticale, une réaction périostée, des bords mal définis, et un dommage des tissus mous environnants. Une probable tumeur à cellules géantes a été diagnostiquée. Le traitement chirurgical a permis la conservation de l'avant-bras, mais un an après l'intervention, son pronostic reste incertain, étant donnée la probabilité de récidive. Conclusions: La rapide croissance des tumeurs exige des décisions opportunes, car le temps parcouru avant le traitement peut se traduire -comme dans ce cas- par une atteinte destructive des tissus adjacents. Plus d'un an après la chirurgie, le pronostic du patient reste incertain, parce que la probabilité de récidive est encore latente(AU)

Tumor de células gigantes en el antebrazo / Forearm giant cell tumor

RESUMEN El tumor de células gigantes se define como un tumor óseo benigno que invade las partes blandas localmente de forma agresiva. Se presenta una paciente con un tumor de células gigantes recidivante en el tercio distal del radio derecho, con signos de necrosis superficial e infección sobreañadidos, la cual, dada la magnitud y severidad de la lesión, requirió una amputación supracondílea de la extremidad. Presentó una evolución postoperatoria favorable, con recuperación física y psicológica(AU)

ABSTRACT Giant cell tumor is defined as a benign bone tumor that aggressively invades soft tissue locally. We present a patient with a recurrent giant cell tumor in the distal third of the right radius, showing signs of superimposed necrosis and infection, which, given the injury magnitude and severity, required supracondylar amputation of the limb. Her postoperative evolution was favorable, and this patient underwent physical and psychological recovery(AU)

RÉSUMÉ La tumeur à cellules géantes est définie comme une tumeur osseuse bénigne qui envahit agressivement les parties molles locales. Une patiente atteinte de tumeur récidivante à cellules géantes au niveau du tiers distal du radius droit, avec signes de nécrose superficielle et d'infection surajoutés, laquelle a requis une amputation supracondylienne du membre, due à la magnitude et à la sévérité de la lésion, est présentée. Elle a montré une évolution postopératoire favorable, avec une bonne récupération physique et psychologique.

[Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques]. / Diagnostic des lésions osseuses riches en cellules géantes : démarche diagnostique et intérêt des nouvelles techniques complémentaires immuno-histochimiques et moléculaires.

The infiltration by numerous osteoclastic giant cells is a frequent finding in bone tumors and pseudo-tumors. Pathologists must integrate clinical and radiological data to achieve a correct diagnosis in bone pathology. Benign giant-cell rich lesions of bone encompass giant cell tumor of bone, aneurysmal bone cyst, chondroblastoma, brown tumor and fibrous cortical defect/non-ossifying fibroma. Amongst malignant neoplasms, variants of conventional osteosarcoma, undifferentiated pleomorphic sarcoma, leiomyosarcoma and bone metastasis must be discussed. Recently, new diagnostic markers, antibodies for immuno-histochemistry and genetic markers, have been developed and are helpful to diagnose such lesions.

Two cases of distal ulna giant cell tumors treated by extensive resection, prosthetic reconstruction and stabilization using the brachioradialis tendon.

Aggressive giant cell tumors are rare at the distal ulna. We report the results of two patients who were treated surgically using a distal ulna prosthesis stabilized by ligament reconstruction with the brachioradialis tendon. At the maximum follow-up of 18months, the two patients were satisfied. Joint range of motion and functional scores were improved. X-rays showed no recurrence or subluxation; however gradual impingement of the ulnar notch of radius by the prosthesis was visible. Our technique seems to be a viable alternative when compared with the treatments described in other published case reports.

Tratamiento de tumores de células gigantes / Traitement des tumeurs à cellules géantes / Treatment of Giant Cell Tumors

Introducción: el tumor de células gigantes se presenta en adultos jóvenes, y su capacidad metastásica obliga a realizar un tratamiento quirúrgico, aunque su tasa de recurrencias hace que no haya consenso respecto a la conducta terapéutica. Método: 23 pacientes fueron intervenidos en el periodo de 1996 a 2012 en el hospital universitario Miguel Servet, a los que se les realizó un seguimiento medio de 8,9 años. Resultados: el resultado funcional fue satisfactorio en todos los casos, pues todos los pacientes pudieron reanudar su actividad física habitual. Se detectaron 6 pacientes con recurrencias que fueron tratadas quirúrgicamente; estos pacientes también tuvieron una recuperación total. Un paciente falleció a causa de metástasis pulmonares. Conclusiones: el tratamiento quirúrgico es el más indicado en tumores de células gigantes, se lograron buenos resultados tanto en el tratamiento del tumor primario como de las recidivas(AU)

Introduction: giant cell tumor occurs in young adults, and their metastatic capacity requires a surgical treatment, although the recurrence rate makes no consensus on the therapeutic approach. Method: twenty-three patients were operated from 1996 to 2012 at Miguel Servet University Hospital; they underwent an 8.9 year-mean follow up. Results: the functional result was satisfactory in all cases, for all patients were able to return their usual physical activity. Six patients with recurrences were surgically treated; these patients also had a full recovery. One patient died of pulmonary metastases. Conclusions: surgical treatment is the most suitable approach in giant cell tumors, good results were achieved both in the treatment of primary tumor as well as of recurrence(AU)

Introduction: La tumeur à cellules géantes se rencontre chez des jeunes adultes, et sa capacité de métastase impose un traitement chirurgical, quoique son taux de récurrence empêche qu'il n'y ait pas de consensus sur la conduite thérapeutique à suivre. Méthodes: Dans la période 1996-2012, vingt-trois patients ont été traités chirurgicalement à l'hôpital universitaire Miguel Servet, et ils ont été suivis pendant une période moyenne de 8,9 ans. Résultats: Il y a eu des résultats satisfaisants en ce qui concerne la fonction, parce que tous les patients ont pu reprendre leurs activités quotidiennes. Dans quelques cas (6 patients), on a détecté des récurrences qui ont été traitées chirurgicalement. La récupération de ces patients a été totale, mais un patient est décédé à cause d'une métastase pulmonaire. Conclusions: Le traitement chirurgical est la conduite la plus appropriée dans les cas de tumeur à cellules géantes. On a obtenu de bons résultats dans le traitement de la tumeur primaire et des récidives(AU)

Tumor de células gigantes del peroné y parálisis del nervio peroneo común / Tumeur à cellules géantes du péroné et paralyse du nerf péronier commun / Giant-cell tumor of the fibula and common peroneal nerve palsy

Los tumores del peroné comprenden solamente el 2,5 por ciento de los tumores primarios de los huesos y solo un tercio de ellos son benignos. El tumor de células gigantes es una lesión benigna, pero puede tener un comportamiento localmente agresivo. Se presenta el caso con el propósito de destacar el tratamiento quirúrgico utilizado con éxito ante un tumor de este tipo. Se trata de un paciente de 30 años de edad con diagnóstico imagenológico e histológico de un tumor de células gigantes del extremo proximal del peroné que produjo una parálisis compresiva del nervio peroneo común. Se realizó una resección en bloque del extremo proximal del peroné y una liberación del nervio peroneo. El tumor era de gran tamaño y aunque no existía infiltración de los tejidos blandos vecinos ya había ruptura de la cortical, por lo que se clasificó como un grado III. Después de dos meses de rehabilitación la movilidad y estabilidad de la rodilla eran normales. El paciente recuperó la función nerviosa a los cinco meses de la operación. Después de 15 meses no había signos clínicos ni imagenológicos de recidiva del tumor. La condición de grado III y la localización del tumor, fueron los dos aspectos tomados en cuenta para la elección de la resección en bloque como tratamiento en este caso, técnica quirúrgica que permiti'o la extracción del tumor sin crear tensiones por tracción excesiva sobre el nervio peroneo común. El paciente está totalmente reintegrado a su vida laboral y personal(AU)

Tumors of the fibula constitute a mere 2.5 percent of the primary tumors of bone, and only one third of them are benign. Giant-cell tumors are a benign lesion, but their behavior may be locally aggressive. This case presentation is aimed at describing the successful treatment of a giant-cell tumor. A 30-year-old male patient with an imaging and histological diagnosis of a giant-cell tumor of the proximal end of the fibula presents with compressive common peroneal nerve palsy. En bloc resection of the proximal end of the fibula and release of the peroneal nerve were performed. The tumor was large. Though there was no infiltration into the neighboring soft tissues, cortical rupture had already occurred. Thus, the tumor was classified as grade III. After two months of rehabilitation, mobility and stability of the knee were normal. Nerve function was recovered 5 months after surgery. At 15 months there were no clinical or imaging signs of tumor recurrence. Grade III classification and location were the two criteria leading to the choice of en bloc resection. This surgical technique enables extraction of the tumor without excessive traction tension on the common peroneal nerve. The patient has fully reintegrated to his work and personal life(AU)

Les tumeurs du péroné ne comprennent que 2,5 pourcent des tumeurs primaires des os, et un tiers d'entre elles sont bénignes. La tumeur à cellules géantes est une lésion bénigne, mais peut avoir un comportement local agressif. Un cas est présenté dans le but de mettre en relief le traitement chirurgical utilisé avec succès vis-à-vis une tumeur de ce type. Il s'agit d'un patient âgé de 30 ans, diagnostiqué par imagerie et histologie d'une tumeur à cellules géantes au côté proximal du péroné résultant en une paralysie par compression du nerf péronier commun. Une résection en bloc du côté proximal du péroné et une libération du nerf péronier sont effectuées. La tumeur est de grande taille, et quoiqu'il n'y a pas d'infiltration des tissus mous en proximité, il y a un rupture de la corticale, c'est pourquoi elle est classée grade III. Après deux mois de rééducation, la mobilité et la stabilité du genou deviennent normales. Le patient récupère la fonction nerveuse en 5 mois. Après 15 mois, il n'y a aucun signe clinique ou radiologique indiquant récidive de la tumeur. C'est la classification en grade III et la localisation de la tumeur qui ont décidé le choix de la résection en bloc comme technique chirurgicale permettant d'enlever la tumeur sans créer des tensions par traction excessive sur le nerf péronier commun. Le patient s'est complètement réintégré à sa vie quotidienne(AU)